Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast

Detalhes bibliográficos
Autor(a) principal: Aguiar,Fernando Nalesso
Data de Publicação: 2013
Outros Autores: Mendes,Henrique Nogueira, Bacchi,Carlos E., Carvalho,Filomena Marino
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista brasileira de ginecologia e obstetrícia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032013000300002
Resumo: PURPOSE:To compare the prognostic and predictive features between in situ and invasive components of ductal breast carcinomas. METHODS:We selected 146 consecutive breast samples with ductal carcinoma in situ (DCIS) associated with adjacent invasive breast carcinoma (IBC). We evaluated nuclear grade and immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), cytokeratin 5/6 (CK5/6), and epidermal growth factor receptor (EGFR) in both components, in situ and invasive, and the Ki-67 percentage of cells in the invasive part. The DCIS and IBC were classified in molecular surrogate types determined by the immunohistochemical profile as luminal (RE/PR-positive/ HER2-negative), triple-positive (RE/RP/HER2-positive), HER2-enriched (ER/PR-negative/HER2-positive), and triple-negative (RE/RP/HER2-negative). Discrimination between luminal A and luminal B was not performed due to statistical purposes. Correlations between the categories in the two groups were made using the Spearman correlation method. RESULTS:There was a significant correlation between nuclear grade (p<0.0001), expression of RE/RP (p<0.0001), overexpression of HER2 (p<0.0001), expression of EGFR (p<0.0001), and molecular profile (p<0.0001) between components in situ and IBC. CK 5/6 showed different distribution in DCIS and IBC, presenting a significant association with the triple-negative phenotype in IBC, but a negative association among DCIS. CONCLUSIONS: Our results suggest that classical prognostic and predictive features of IBC are already determined in the preinvasive stage of the disease. However the role of CK5/6 in invasive carcinoma may be different from the precursor lesions.
id FEBRASGO-1_67794a637695dbc446f584442525bf27
oai_identifier_str oai:scielo:S0100-72032013000300002
network_acronym_str FEBRASGO-1
network_name_str Revista brasileira de ginecologia e obstetrícia (Online)
repository_id_str
spelling Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breastBreast neoplasms/chemistryCarcinoma, ductal, breast/chemistryImmunoenzyme techniquesReceptors, estrogen/analysisReceptor, erbB-2/analysiskeratin-5/analysiskeratin-6/analysisKi-67 antigen/analysisTumor makers, biologicalPURPOSE:To compare the prognostic and predictive features between in situ and invasive components of ductal breast carcinomas. METHODS:We selected 146 consecutive breast samples with ductal carcinoma in situ (DCIS) associated with adjacent invasive breast carcinoma (IBC). We evaluated nuclear grade and immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), cytokeratin 5/6 (CK5/6), and epidermal growth factor receptor (EGFR) in both components, in situ and invasive, and the Ki-67 percentage of cells in the invasive part. The DCIS and IBC were classified in molecular surrogate types determined by the immunohistochemical profile as luminal (RE/PR-positive/ HER2-negative), triple-positive (RE/RP/HER2-positive), HER2-enriched (ER/PR-negative/HER2-positive), and triple-negative (RE/RP/HER2-negative). Discrimination between luminal A and luminal B was not performed due to statistical purposes. Correlations between the categories in the two groups were made using the Spearman correlation method. RESULTS:There was a significant correlation between nuclear grade (p<0.0001), expression of RE/RP (p<0.0001), overexpression of HER2 (p<0.0001), expression of EGFR (p<0.0001), and molecular profile (p<0.0001) between components in situ and IBC. CK 5/6 showed different distribution in DCIS and IBC, presenting a significant association with the triple-negative phenotype in IBC, but a negative association among DCIS. CONCLUSIONS: Our results suggest that classical prognostic and predictive features of IBC are already determined in the preinvasive stage of the disease. However the role of CK5/6 in invasive carcinoma may be different from the precursor lesions.Federação Brasileira das Sociedades de Ginecologia e Obstetrícia2013-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032013000300002Revista Brasileira de Ginecologia e Obstetrícia v.35 n.3 2013reponame:Revista brasileira de ginecologia e obstetrícia (Online)instname:Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)instacron:FEBRASGO10.1590/S0100-72032013000300002info:eu-repo/semantics/openAccessAguiar,Fernando NalessoMendes,Henrique NogueiraBacchi,Carlos E.Carvalho,Filomena Marinoeng2013-03-25T00:00:00Zoai:scielo:S0100-72032013000300002Revistahttp://www.scielo.br/rbgohttps://old.scielo.br/oai/scielo-oai.phppublicações@febrasgo.org.br||rbgo@fmrp.usp.br1806-93390100-7203opendoar:2013-03-25T00:00Revista brasileira de ginecologia e obstetrícia (Online) - Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)false
dc.title.none.fl_str_mv Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
title Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
spellingShingle Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
Aguiar,Fernando Nalesso
Breast neoplasms/chemistry
Carcinoma, ductal, breast/chemistry
Immunoenzyme techniques
Receptors, estrogen/analysis
Receptor, erbB-2/analysis
keratin-5/analysis
keratin-6/analysis
Ki-67 antigen/analysis
Tumor makers, biological
title_short Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
title_full Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
title_fullStr Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
title_full_unstemmed Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
title_sort Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast
author Aguiar,Fernando Nalesso
author_facet Aguiar,Fernando Nalesso
Mendes,Henrique Nogueira
Bacchi,Carlos E.
Carvalho,Filomena Marino
author_role author
author2 Mendes,Henrique Nogueira
Bacchi,Carlos E.
Carvalho,Filomena Marino
author2_role author
author
author
dc.contributor.author.fl_str_mv Aguiar,Fernando Nalesso
Mendes,Henrique Nogueira
Bacchi,Carlos E.
Carvalho,Filomena Marino
dc.subject.por.fl_str_mv Breast neoplasms/chemistry
Carcinoma, ductal, breast/chemistry
Immunoenzyme techniques
Receptors, estrogen/analysis
Receptor, erbB-2/analysis
keratin-5/analysis
keratin-6/analysis
Ki-67 antigen/analysis
Tumor makers, biological
topic Breast neoplasms/chemistry
Carcinoma, ductal, breast/chemistry
Immunoenzyme techniques
Receptors, estrogen/analysis
Receptor, erbB-2/analysis
keratin-5/analysis
keratin-6/analysis
Ki-67 antigen/analysis
Tumor makers, biological
description PURPOSE:To compare the prognostic and predictive features between in situ and invasive components of ductal breast carcinomas. METHODS:We selected 146 consecutive breast samples with ductal carcinoma in situ (DCIS) associated with adjacent invasive breast carcinoma (IBC). We evaluated nuclear grade and immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), cytokeratin 5/6 (CK5/6), and epidermal growth factor receptor (EGFR) in both components, in situ and invasive, and the Ki-67 percentage of cells in the invasive part. The DCIS and IBC were classified in molecular surrogate types determined by the immunohistochemical profile as luminal (RE/PR-positive/ HER2-negative), triple-positive (RE/RP/HER2-positive), HER2-enriched (ER/PR-negative/HER2-positive), and triple-negative (RE/RP/HER2-negative). Discrimination between luminal A and luminal B was not performed due to statistical purposes. Correlations between the categories in the two groups were made using the Spearman correlation method. RESULTS:There was a significant correlation between nuclear grade (p<0.0001), expression of RE/RP (p<0.0001), overexpression of HER2 (p<0.0001), expression of EGFR (p<0.0001), and molecular profile (p<0.0001) between components in situ and IBC. CK 5/6 showed different distribution in DCIS and IBC, presenting a significant association with the triple-negative phenotype in IBC, but a negative association among DCIS. CONCLUSIONS: Our results suggest that classical prognostic and predictive features of IBC are already determined in the preinvasive stage of the disease. However the role of CK5/6 in invasive carcinoma may be different from the precursor lesions.
publishDate 2013
dc.date.none.fl_str_mv 2013-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032013000300002
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032013000300002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-72032013000300002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
publisher.none.fl_str_mv Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
dc.source.none.fl_str_mv Revista Brasileira de Ginecologia e Obstetrícia v.35 n.3 2013
reponame:Revista brasileira de ginecologia e obstetrícia (Online)
instname:Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)
instacron:FEBRASGO
instname_str Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)
instacron_str FEBRASGO
institution FEBRASGO
reponame_str Revista brasileira de ginecologia e obstetrícia (Online)
collection Revista brasileira de ginecologia e obstetrícia (Online)
repository.name.fl_str_mv Revista brasileira de ginecologia e obstetrícia (Online) - Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)
repository.mail.fl_str_mv publicações@febrasgo.org.br||rbgo@fmrp.usp.br
_version_ 1754115942139297793